OPEN END TURBO BEAR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000HC87WH2

Real-time BOERSE MUENCHEN 01:15:16 28/06/2024 am IST
1.3 EUR -0.76% Intraday chart for OPEN END TURBO BEAR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month+35.42%
1 month+30.00%
Date Price Change
27/24/27 1.3 -0.76%
26/24/26 1.31 +0.77%
25/24/25 1.3 +3.17%
24/24/24 1.26 -4.55%
21/24/21 1.32 +7.32%

Real-time BOERSE MUENCHEN

Last update June 28, 2024 at 01:15 am IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC87WH
ISINDE000HC87WH2
Date issued 25/07/2023
Strike 48.72
Maturity Unlimited
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.89
Lowest since issue 0.17

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.72 EUR
Average target price
39.97 EUR
Spread / Average Target
+11.91%
Consensus